
|Articles|November 1, 2009
Research points to expanding role of botulinum toxin
Author(s)Philip M. Hanno, MD, MPH
In this podcast, Dr. Phil Hanno interviews Dr. Michael Chancellor on the potential role of botulinum toxin in urology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of molecular glue degrader plus apalutamide in mCRPC
2
How ARASEC and ARACOG are reshaping mCSPC treatment choices
3
ASCO 2026: 3 key themes shaping the future of GU oncology
4
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
5







